Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Viking Therapeutics Inc (NASDAQ: VKTX) closed at $31.52 in the last session, down -3.76% from day before closing price of $32.75. In other words, the price has decreased by -$3.76 from its previous closing price. On the day, 3.92 million shares were traded. VKTX stock price reached its highest trading level at $32.4 during the session, while it also had its lowest trading level at $31.13.
Ratios:
We take a closer look at VKTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 36.47 and its Current Ratio is at 36.47. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On November 22, 2024, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $109.
H.C. Wainwright reiterated its Buy rating for the stock on November 04, 2024, while the target price for the stock was revised from $90 to $102.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 06 ’25 when Lian Brian sold 194,490 shares for $42.75 per share. The transaction valued at 8,313,601 led to the insider holds 2,366,570 shares of the business.
Mancini Marianna sold 54,215 shares of VKTX for $2,317,599 on Jan 06 ’25. The Chief Operating Officer now owns 374,134 shares after completing the transaction at $42.75 per share. On Jan 06 ’25, another insider, ZANTE GREG, who serves as the Chief Financial Officer of the company, sold 50,309 shares for $42.75 each. As a result, the insider received 2,150,595 and left with 165,259 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VKTX now has a Market Capitalization of 3512462848 and an Enterprise Value of 2583269888.
Stock Price History:
The Beta on a monthly basis for VKTX is 0.89, which has changed by 0.33075988 over the last 52 weeks, in comparison to a change of 0.21926713 over the same period for the S&P500. Over the past 52 weeks, VKTX has reached a high of $99.41, while it has fallen to a 52-week low of $22.51. The 50-Day Moving Average of the stock is -26.26%, while the 200-Day Moving Average is calculated to be -44.75%.
Shares Statistics:
According to the various share statistics, VKTX traded on average about 4.35M shares per day over the past 3-months and 3727620 shares per day over the past 10 days. A total of 111.43M shares are outstanding, with a floating share count of 107.97M. Insiders hold about 3.11% of the company’s shares, while institutions hold 72.52% stake in the company. Shares short for VKTX as of 1736899200 were 20200041 with a Short Ratio of 4.64, compared to 1734048000 on 18296112. Therefore, it implies a Short% of Shares Outstanding of 20200041 and a Short% of Float of 24.350001.
